| Kelly Jones, CRNA | |
|
2006 Limestone Rd, Suite 5, Wilmington, DE 19808-5553 | |
| (302) 995-1860 | |
| (302) 995-5421 |
| Full Name | Kelly Jones |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 19 Years |
| Location | 2006 Limestone Rd, Wilmington, Delaware |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588698971 | NPI | - | NPPES |
| P00261465 | Other | DE | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | L6-0A00444 (Delaware) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ncb Anesthesia Associates, Llc | 1557726130 | 19 |
News Archive
The study was categorized as a primary prevention trial for coronary heart disease, although the fact that mean age at recruitment was 63 years was not given enough importance at that time. WHI investigators concluded that hormone therapy (HT) was not cardioprotective, and, in fact, its riskbenefit ratio did not favor the use of postmenopausal hormones for prevention of chronic diseases.
Xstrahl, a designer and manufacturer of a world-renowned range of superficial and orthovoltage radiotherapy systems that have been essential in supporting healthcare professionals and their patients in over 500 clinics for the past 15 years, today announces the launch of Imperium, a new control system for its X-ray therapy system, at this year's ASTRO conference in San Diego, 31 October - 4 November.
McKesson Corporation, a leading North American healthcare services and information technology company, and Celesio AG, a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sectors, announced today that McKesson has signed an agreement to acquire a majority stake in Celesio for €23 per share and to launch parallel voluntary public tender offers for the remaining publicly-traded shares and outstanding convertible bonds of Celesio.
Nurses and other health professionals looking to integrate genomics into patient care now have access to an online toolkit with more than 100 resources, part of a new website launched by the National Human Genome Research Institute.
In Germany, nearly 6 million people suffer from coronary heart disease. The disease is caused by calcium deposits which constrict the coronary arteries. Doctors generally use a stent to widen the narrow pathway.
› Verified 9 days ago
| Entity Name | North American Partners In Anesthesia Delaware Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639110406 PECOS PAC ID: 0941113484 Enrollment ID: O20031211000736 |
News Archive
The study was categorized as a primary prevention trial for coronary heart disease, although the fact that mean age at recruitment was 63 years was not given enough importance at that time. WHI investigators concluded that hormone therapy (HT) was not cardioprotective, and, in fact, its riskbenefit ratio did not favor the use of postmenopausal hormones for prevention of chronic diseases.
Xstrahl, a designer and manufacturer of a world-renowned range of superficial and orthovoltage radiotherapy systems that have been essential in supporting healthcare professionals and their patients in over 500 clinics for the past 15 years, today announces the launch of Imperium, a new control system for its X-ray therapy system, at this year's ASTRO conference in San Diego, 31 October - 4 November.
McKesson Corporation, a leading North American healthcare services and information technology company, and Celesio AG, a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sectors, announced today that McKesson has signed an agreement to acquire a majority stake in Celesio for €23 per share and to launch parallel voluntary public tender offers for the remaining publicly-traded shares and outstanding convertible bonds of Celesio.
Nurses and other health professionals looking to integrate genomics into patient care now have access to an online toolkit with more than 100 resources, part of a new website launched by the National Human Genome Research Institute.
In Germany, nearly 6 million people suffer from coronary heart disease. The disease is caused by calcium deposits which constrict the coronary arteries. Doctors generally use a stent to widen the narrow pathway.
› Verified 9 days ago
| Entity Name | Compton Anesthesiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568792364 PECOS PAC ID: 2668653551 Enrollment ID: O20110225000103 |
News Archive
The study was categorized as a primary prevention trial for coronary heart disease, although the fact that mean age at recruitment was 63 years was not given enough importance at that time. WHI investigators concluded that hormone therapy (HT) was not cardioprotective, and, in fact, its riskbenefit ratio did not favor the use of postmenopausal hormones for prevention of chronic diseases.
Xstrahl, a designer and manufacturer of a world-renowned range of superficial and orthovoltage radiotherapy systems that have been essential in supporting healthcare professionals and their patients in over 500 clinics for the past 15 years, today announces the launch of Imperium, a new control system for its X-ray therapy system, at this year's ASTRO conference in San Diego, 31 October - 4 November.
McKesson Corporation, a leading North American healthcare services and information technology company, and Celesio AG, a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sectors, announced today that McKesson has signed an agreement to acquire a majority stake in Celesio for €23 per share and to launch parallel voluntary public tender offers for the remaining publicly-traded shares and outstanding convertible bonds of Celesio.
Nurses and other health professionals looking to integrate genomics into patient care now have access to an online toolkit with more than 100 resources, part of a new website launched by the National Human Genome Research Institute.
In Germany, nearly 6 million people suffer from coronary heart disease. The disease is caused by calcium deposits which constrict the coronary arteries. Doctors generally use a stent to widen the narrow pathway.
› Verified 9 days ago
| Entity Name | Ncb Anesthesia Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962102582 PECOS PAC ID: 1557726130 Enrollment ID: O20230504000303 |
News Archive
The study was categorized as a primary prevention trial for coronary heart disease, although the fact that mean age at recruitment was 63 years was not given enough importance at that time. WHI investigators concluded that hormone therapy (HT) was not cardioprotective, and, in fact, its riskbenefit ratio did not favor the use of postmenopausal hormones for prevention of chronic diseases.
Xstrahl, a designer and manufacturer of a world-renowned range of superficial and orthovoltage radiotherapy systems that have been essential in supporting healthcare professionals and their patients in over 500 clinics for the past 15 years, today announces the launch of Imperium, a new control system for its X-ray therapy system, at this year's ASTRO conference in San Diego, 31 October - 4 November.
McKesson Corporation, a leading North American healthcare services and information technology company, and Celesio AG, a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sectors, announced today that McKesson has signed an agreement to acquire a majority stake in Celesio for €23 per share and to launch parallel voluntary public tender offers for the remaining publicly-traded shares and outstanding convertible bonds of Celesio.
Nurses and other health professionals looking to integrate genomics into patient care now have access to an online toolkit with more than 100 resources, part of a new website launched by the National Human Genome Research Institute.
In Germany, nearly 6 million people suffer from coronary heart disease. The disease is caused by calcium deposits which constrict the coronary arteries. Doctors generally use a stent to widen the narrow pathway.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kelly Jones, CRNA 2006 Limestone Rd, Suite 5, Wilmington, DE 19808-5553 Ph: (302) 995-1860 | Kelly Jones, CRNA 2006 Limestone Rd, Suite 5, Wilmington, DE 19808-5553 Ph: (302) 995-1860 |
News Archive
The study was categorized as a primary prevention trial for coronary heart disease, although the fact that mean age at recruitment was 63 years was not given enough importance at that time. WHI investigators concluded that hormone therapy (HT) was not cardioprotective, and, in fact, its riskbenefit ratio did not favor the use of postmenopausal hormones for prevention of chronic diseases.
Xstrahl, a designer and manufacturer of a world-renowned range of superficial and orthovoltage radiotherapy systems that have been essential in supporting healthcare professionals and their patients in over 500 clinics for the past 15 years, today announces the launch of Imperium, a new control system for its X-ray therapy system, at this year's ASTRO conference in San Diego, 31 October - 4 November.
McKesson Corporation, a leading North American healthcare services and information technology company, and Celesio AG, a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sectors, announced today that McKesson has signed an agreement to acquire a majority stake in Celesio for €23 per share and to launch parallel voluntary public tender offers for the remaining publicly-traded shares and outstanding convertible bonds of Celesio.
Nurses and other health professionals looking to integrate genomics into patient care now have access to an online toolkit with more than 100 resources, part of a new website launched by the National Human Genome Research Institute.
In Germany, nearly 6 million people suffer from coronary heart disease. The disease is caused by calcium deposits which constrict the coronary arteries. Doctors generally use a stent to widen the narrow pathway.
› Verified 9 days ago
Christine Moses, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2006 Limestone Rd, Suite 5, Wilmington, DE 19808 Phone: 302-995-1860 Fax: 302-995-5421 | |
Ms. Melinda S. Brown, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1600 Rockland Rd, Nemours Dupont Pediatrics, Wilmington, DE 19803 Phone: 302-651-4200 Fax: 302-651-5365 | |
Ms. Carolyn R Sweeney, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1600 Rockland Road, Wilmington, DE 19803 Phone: 302-651-4200 Fax: 302-651-5365 | |
William G Devece, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 701 N. Clayton St., 4th Floor, Wilmington, DE 19805 Phone: 302-421-4330 Fax: 302-421-4331 | |
Martha Dawn Turner, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1601 Kirkwood Hwy, Wilmington, DE 19805 Phone: 302-994-2511 | |
Leslie K Jackson, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1600 Rockland Road, Wilmington, DE 19803 Phone: 302-651-4200 Fax: 302-651-5365 | |
Nicholas Stuardi, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2006 Limestone Rd, Suite 5, Wilmington, DE 19808 Phone: 302-995-1860 Fax: 302-995-5421 |